1.Periodontopathogen profile of healthy and oral lichen planus patients with gingivitis or periodontitis.
Abdullah Seckin ERTUGRUL ; Ugur ARSLAN ; Recep DURSUN ; Sema Sezgin HAKKI
International Journal of Oral Science 2013;5(2):92-97
Oral lichen planus (OLP) is a chronic inflammatory disease that is frequently detected in oral tissues. The aim of our study was to identify the prevalence of the detection of periodontopathogenic microorganisms (Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Prevotella intermedia, Tannerella forsythia and Treponema denticola in OLP patients and to compare with this prevalence of periodontopathogenic microorganisms in healthy non-OLP patients. Our study included 27 (18 chronic periodontitis (OLPP) and 9 gingivitis (OLPG)) patients diagnosed with OLP along with 26 (13 chronic periodontitis (HP) and 13 gingivitis (HG)) healthy non-OLP patients. The multiplex polymerase chain reaction (PCR) with subsequent reverse hybridization method (micro-IDent) was used for identifying periodontopathogenic microorganisms present in subgingival plaque samples. The percentages of detection for A. actinomycetemcomitans, P. gingivalis, P. intermedia, T. forsythia and T. denticola in subgingival plaque samples taken from OLP patients (OLPG and OLPP) were 18.5%, 85.1%, 81.4%, 88.8% and 74%, respectively. Meanwhile, in the non-OLP patients (HG and HP), these values were 7.6%, 50%, 46.1%, 73% and 57.7%, respectively. Thus, comparing the non-OLP groups with the OLP groups, the periodontopathogens' percentages of detection in the OLP groups were higher than those in the non-OLP groups. According to our study results, OLP patients have higher levels of infection with A. actinomycetemcomitans, P. gingivalis, P. intermedia, T. forsythia and T. denticola than non-OLP patients. We argue that the high percentages in patients with OLP may help identify the importance of periodontopathogenic microorganisms in the progress of periodontal diseases of OLP.
Actinobacillus Infections
;
diagnosis
;
Adult
;
Aggregatibacter actinomycetemcomitans
;
isolation & purification
;
Bacteroidaceae Infections
;
diagnosis
;
Bacteroides
;
isolation & purification
;
Bacteroides Infections
;
diagnosis
;
Chronic Periodontitis
;
microbiology
;
Dental Plaque
;
microbiology
;
Dental Plaque Index
;
Female
;
Gingivitis
;
microbiology
;
Gram-Negative Bacteria
;
isolation & purification
;
Humans
;
Lichen Planus, Oral
;
microbiology
;
Male
;
Middle Aged
;
Periodontal Attachment Loss
;
microbiology
;
Periodontal Index
;
Periodontal Pocket
;
microbiology
;
Porphyromonas gingivalis
;
isolation & purification
;
Prevotella intermedia
;
isolation & purification
;
Treponema denticola
;
isolation & purification
;
Treponemal Infections
;
diagnosis
2.Is Hyperbaric Oxygen Therapy Effective in Cisplatin-Induced Ototoxicity in Rats?
H Bengu COBANOGLU ; Erkan VURALKAN ; Abdullah ARSLAN ; Bengusu MIRASOGLU ; A Savas TOKLU
Clinical and Experimental Otorhinolaryngology 2019;12(1):66-71
OBJECTIVES: Cisplatin is an antineoplastic agent, used in the treatment of different types of malignant neoplasms. Side effects such as ototoxicity, nephrotoxicity, and bone marrow toxicity are the main limitations of its clinical use. The aim of the present study was to evaluate the possible effects of hyperbaric oxygen (HBO) therapy as a protective agent in cisplatin-induced ototoxicity in rats. METHODS: A total of 30 adult Wistar rats (60 ears) were divided into five equal groups. Group 1 is a control group; group 2 is HBO therapy group; group 3 received 15 mg/kg cisplatin intraperitoneally; group 4 received 15 mg/kg cisplatin intraperitoneally and HBO treatment on the same day; group 5 received 15 mg/kg cisplatin intraperitoneally and HBO treatment 72 hours later. The effect of ototoxicity was measured with distortion product otoacoustic emission testing performed on the days 1, 3, and 7. RESULTS: Groups 4 and 5 that received HBO treatment after cisplatin had better signal-to-noise ratio (SNR) values compared with group 3 that received only cisplatin (P < 0.05). Compared with group 5, group 4 (same day HBO treatment) had better SNR values (P < 0.05). CONCLUSION: HBO was found effective for prevention of cisplatin-induced ototoxicity in rats. Our study differs from other studies regarding using a promising treatment, which does not expose subjects to extra stress.
Adult
;
Animals
;
Bone Marrow
;
Cisplatin
;
Humans
;
Hyperbaric Oxygenation
;
Oxygen
;
Rats
;
Rats, Wistar
;
Signal-To-Noise Ratio
3.Influence of vaccine potency and booster administration of foot-and-mouth disease vaccines on the antibody response in calves with maternal antibodies.
Can ÇOKÇALIŞKAN ; Tunçer TÜRKOĞLU ; Ergün UZUNLU ; Beyhan SAREYYÜPOĞLU ; Ibrahim HANCI ; Ahmet İPEK ; Abdullah ARSLAN ; Ayca BABAK ; Gülnur İLDENIZ ; Veli GÜLYAZ
Journal of Veterinary Science 2017;18(S1):315-322
Foot-and-mouth disease is one of the most important viral diseases of cloven-hoofed animals. Mass vaccination is an effective method to control the disease and is frequently utilized in endemic regions. Sufficient protection of young animals is important in mass vaccination campaigns. Maternal antibodies negatively affect the success of vaccination. Hence, determination of the optimal vaccination age is crucial for the uninterrupted protection of young animals. This study was performed to identify the effect of vaccine potency and booster administration on serum neutralizing antibody titers of calves with different levels of maternal antibodies. Calves (n = 111) on a state farm were used in this study. Oil adjuvant foot-and-mouth disease vaccines with 3 PD₅₀ and 6 PD₅₀ potencies were used with or without booster administration. Serum samples were collected each month up to day 120 postvaccination. Virus neutralization tests were used to measure the serum neutralizing antibody titers and estimate the protection period by using pre-determined cut-off values for protection. The results revealed that a vaccination with a 6 PD₅₀ potency vaccine, preferably followed by a booster dose, should be used to overcome maternal immunity for incessant protection.
Agriculture
;
Animals
;
Antibodies*
;
Antibodies, Neutralizing
;
Antibody Formation*
;
Foot-and-Mouth Disease*
;
Mass Vaccination
;
Methods
;
Neutralization Tests
;
Vaccination
;
Vaccine Potency*
;
Vaccines*
;
Virus Diseases